CX-4945 oral formulation ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
331	Idiopathic multicentric castleman disease	1

331. Idiopathic multicentric castleman disease

Clinical trials : 33 / Drugs : 46 - (DrugBank : 25) / Drug target genes : 31 - Drug target pathways : 155

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00891280 (ClinicalTrials.gov)	February 2009	29/4/2009	Dose-escalation Study of Oral CX-4945	A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic S ...	Advanced Solid Tumors;Breast Cancer;Inflammatory Breast Cancer;Castleman's Disease;Multiple Myeloma	Drug: CX-4945 oral formulation	Cylene Pharmaceuticals	NULL	Recruiting	18 Years	N/A	Both	55	Phase 1	United States

First Previous1Next Last